Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
10.3M
-
Shares change
-
+472K
-
Total reported value, excl. options
-
$90.7M
-
Value change
-
+$4.18M
-
Number of buys
-
22
-
Number of sells
-
-6
-
Price
-
$8.80
Significant Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q1 2017
36 filings reported holding KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share as of Q1 2017.
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.3M shares
of 87M outstanding shares and own 11.85% of the company stock.
Largest 10 shareholders include FMR LLC (2.82M shares), EcoR1 Capital, LLC (2.61M shares), Partner Fund Management, L.P. (2.03M shares), Boxer Capital, LLC (533K shares), Clough Capital Partners L P (501K shares), MORGAN STANLEY (430K shares), VANGUARD GROUP INC (384K shares), Minerva Advisors LLC (297K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (92.2K shares), and Alethea Capital Management, LLC (84.8K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.